CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement · Shareholder vote results
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- DEFA14A Proxy Proxy Materials
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
- 4 Grant or award EVP and CSO acquired 4,526 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,862 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 15,329 shares (grant or award)
- 4 Grant or award EVP, CLO and CCO acquired 5,475 shares (grant or award)
- 4 Grant or award EVP and Chief Medical Officer acquired 4,526 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 19,455 shares at $5.04 ($98,053)
- 4 Open-market buy SVP and CFO bought 4,864 shares at $5.04 ($24,515)
Page 3 of 25 · 494 filings